Abstract

Leukotrienes (LTs) are lipid messengers generated by leukocytes that drive inflammation and modulate neighboring cell function. The synthesis of LTs from arachidonic acid is initiated by the enzyme 5-lipoxygenase (5-LO). We report for the first time that LT synthesis is inhibited by the direct action of protein kinase A (PKA) on 5-LO. The catalytic subunit of PKA directly phosphorylated 5-LO in vivo and in vitro and inhibited activity in intact cells and in vitro. Mutation of Ser-523 on human 5-LO prevented phosphorylation by PKA and restored LT synthesis. Treatment with PKA activators inhibited LTB(4) synthesis in 3T3 cells expressing wild type 5-LO but not in cells expressing the S523A mutant of 5-LO. The mechanism of inhibition of LTB(4) synthesis did not involve either reduced membrane association of activated 5-LO or redistribution of 5-LO from the nucleus to the cytoplasm. Instead, PKA phosphorylation of recombinant 5-LO inhibited in vitro activity, as did co-transfection of cells with 5-LO plus the catalytic subunit of PKA. Also, substitution of Ser-523 with glutamic acid, mimicking phosphorylation, resulted in the total loss of 5-LO activity. These results indicate that PKA phosphorylates 5-LO on Ser-523, which inhibits the catalytic activity of 5-LO and reduces cellular LT generation. Thus, PKA activation, as can occur in response to adenosine, prostaglandin E(2), beta-adrenergic agonists, and other mediators, is a means of directly reducing 5-LO activity and LT synthesis that may be important in limiting inflammation and maintaining homeostasis.

Highlights

  • Leukotrienes (LTs) are lipid messengers generated by leukocytes that drive inflammation and modulate neighboring cell function

  • We report for the first time that LT synthesis is inhibited by the direct action of protein kinase A (PKA)

  • PKA activation, as can occur in response to adenosine, prostaglandin E2, ␤-adrenergic agonists, and other mediators, is a means of directly reducing 5-LO activity and LT synthesis that may be important in limiting inflammation and maintaining homeostasis

Read more

Summary

EXPERIMENTAL PROCEDURES

Sequence and Structural Analysis—Amino acid sequences were obtained from the Swiss Protein Database from the ExPaSy Analysis of Eicosanoid Profile of 5-LO Metabolism—To evaluate the effect of PKA activity on the formation of different 5-LO products, 3T3 cells (1.6 ⫻ 106 cells) were co-transfected with 2 ␮g of p5-LO or p5LOS523A, 2 ␮g of plasmid encoding FLAP (a generous gift of Dr. Diego, CA), and 2 ␮g of pCMVC␣ or its parent vector pCMVneo. The. 5-LO activity of recombinant 5-LO or cell lysates (200 ␮g of total protein) was determined in 0.25-ml reaction mixtures containing 50 mM. Cells were harvested 16 h after transfection, washed with phosphate-buffered saline, and sonicated for 90 s in 10-s bursts on ice in 1 ml of lysis buffer containing 50 mM Tris-HCl (pH 7.5), 0.1 mM EDTA, 1 mM dithiothreitol, and protease inhibitor mixture. Pairs of group means were analyzed using the TukeyKramer after test

RESULTS
DISCUSSION
Deleted in proof
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call